CALGARY, March 3, 2015 /CNW/ - Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, REOLYSIN®, for the treatment of primary peritoneal cancers.
Intel chose TowerJazz's CMOS image sensor (CIS) platform, specifically its unique IS11 process, due to its unparalleled pixel performance at near infrared light with very high speed, high quantum efficiency (QE) and high optical resolution.
Sentiment: Strong Buy
Yep! There are a lot. Check out the GENE board over past 8 days. They didn't ever know they were buying ADRs, nor knew what they were. Sheep lot of Sheep. Bring out the Clippers
LOOK UP " BIOC"...they have a blood test headed for approval....if its APPROVED THE STOCK WILL EXPLODE! jUST BLOOD, NO CUTTING!
GENE is not even the Stocks name in Australia! GENE is an ADR representing 150 share of GTG the real stock that's traded on ASX exchange. The last few weeks traders have bought like Sheep, some made money, some got fleeced!f
Nice work, but as you can see, folks here think it should be higher. Add to the fact, we were driving the GTG price all last week. Aussie shareholders thought it was Christmas.
The Company has great promise, but it's hard to value. Look at BIOC, at least it's listed here in USA.
Agreed...I can't believe traders are still chasing GENE (really an unknown Company)
is an ADR worth 150 shares of GTG in AUS$ currency.
Is the US driving the share price, or the Company in the Country it's located?
BIOC is a great Stock with a Blood test that will set standards for Breast CA care.
You are correct. Approved bloo test to replace biopsy for treating Breast CA. US Company.
Gene is selling ADRs worth 150 shares of GTG in Aussieland....What a mess